Laurus Labs completes acquisition of 72.55% stake in Richcore Lifesciences Laurus Labs completes acquisition of 72.55% stake in Richcore Lifesciences
Laurus Labs inks pact with ImmunoACT to acquire 26% stake for ₹46 cr Laurus Labs inks pact with ImmunoACT to acquire 26% stake for ₹46 cr Additionally, senior management of Laurus Labs would also invest in ImmunoACT for a 5.64 per cent stake.
Laurus Labs’ net down 17 per cent at ₹202 cr in Q2 Laurus Labs’ net down 17 per cent at ₹202 cr in Q2 Revenue up 6 per cent at Rs 1,203 crore
Laurus Labs developing HIV medication for children The development is based on an agreement with Unitaid and Clinton Health Access Initiative
Laurus Labs gets licence to manufacture, market 2DG The company has applied for emergency use authorisation
How ‘shopoholic’ UPL adds muscle with takeovers Homegrown agrochem MNC UPL believes in collaborations to drive growth and revenue
Birla-Adani in cement slugfest to be top player With housing and roads expected see a boom, cement makers will be jockeying for the top slot
Matrimony.com buyback: Should you say Yes or No? While there may be more steam left in terms of growth opportunities, given the premium valuation the buyback is offering, existing investors can tende
Zomato-Blinkit deal: Quick commerce and late profits The acquisition does not turn the tables for now
Auroville: An utopian search for a better world Akash Kapur’s ‘Better to Have Gone’ traces what happens when we believe deeply in a quest and give up everything in its pursuit
Lady doctors and the rocky path to healing A handbook on India’s first women doctors holds up a mirror to the social and political realities of the 19th and early 20th century
Conquering Everest: A compelling account of how an impossible dream was achieved Jim Davidson dwells in detail on the failure to make it in the first attempt and the harrowing return to physically and emotionally draining climb up
